Oscar Health (OSCR) Stock Is Soaring: Here's Why

Benzinga_recent_news11-27

Oscar Health Inc (NYSE:OSCR) shares are surging Wednesday, driven by a combination of a bullish analyst pivots and regulatory tailwinds. Here’s what investors need to know. What To Know: Piper Sandler...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2586026199?lang=en_US&edition=fundamental","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/11/26/Oscar-Health--Inc.jpeg?optimize=medium&dpr=2&auto=webp&width=240","is_english":true,"pubTime":"2025-11-27 01:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2586026199","market":"us","top_or_hot":-1,"title":"Oscar Health (OSCR) Stock Is Soaring: Here's Why","media":"Benzinga_recent_news","content":"<div>\n<p>Oscar Health Inc (NYSE:OSCR) shares are surging Wednesday, driven by a combination of a bullish analyst pivots and regulatory tailwinds. Here’s what investors need to know.\nWhat To Know: Piper Sandler...</p>\n\n<a href=\"https://www.benzinga.com/trading-ideas/movers/25/11/49090317/oscar-health-oscr-stock-is-soaring-heres-why\">Source Link</a>\n\n</div>\n","source":"benzinga_recent_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Oscar Health (OSCR) Stock Is Soaring: Here's Why</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOscar Health (OSCR) Stock Is Soaring: Here's Why\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-11-27 01:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/trading-ideas/movers/25/11/49090317/oscar-health-oscr-stock-is-soaring-heres-why><strong>Benzinga_recent_news</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Oscar Health Inc (NYSE:OSCR) shares are surging Wednesday, driven by a combination of a bullish analyst pivots and regulatory tailwinds. Here’s what investors need to know.\nWhat To Know: Piper Sandler...</p>\n\n<a href=\"https://www.benzinga.com/trading-ideas/movers/25/11/49090317/oscar-health-oscr-stock-is-soaring-heres-why\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4162","symbol_name":"人寿与健康保险","start_time":0,"source_url":"https://www.benzinga.com/trading-ideas/movers/25/11/49090317/oscar-health-oscr-stock-is-soaring-heres-why","article_id":"2586026199","we_media_id":null,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/11/26/Oscar-Health--Inc.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/trading-ideas/movers/25/11/49090317/oscar-health-oscr-stock-is-soaring-heres-why","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2586026199","pubTimestamp":1764177600,"columns":[],"sourceInfo":{"source_id":"benzinga_recent_news","name":"Benzinga"},"weMediaInfo":null,"summary":"Oscar Health Inc (NYSE: OSCR) shares are surging Wednesday, driven by a combination of a bullish analyst pivots and regulatory tailwinds.","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4162":"人寿与健康保险","BK4551":"寇图资本持仓","OSCR":"Oscar Health, Inc."},"translate_title":"奥斯卡健康(OSCR)股票飙升：原因如下","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OSCR":1.5},"content_text":"Oscar Health Inc (NYSE:OSCR) shares are surging Wednesday, driven by a combination of a bullish analyst pivots and regulatory tailwinds. Here’s what investors need to know.\nWhat To Know: Piper Sandler upgraded the stock from Neutral to Overweight on Wednesday, nearly doubling its price target from $13 to $25, driving bullish momentum. \nHowever, the central driver this week is the White House's imminent framework to extend Affordable Care Act subsidies. Unlike diversified peers like UnitedHealth, Oscar's business model is uniquely tethered to the individual exchange market.\nThe administration’s proposal to extend subsidies for two years and raise eligibility caps to 700% of the federal poverty line is an existential win for the company.\nWhy This Matters: Without this extension, Oscar faced a fiscal cliff where expiring subsidies would skyrocket consumer premiums. This typically forces healthy members to drop coverage, also know as churn, leaving the insurer with a smaller, sicker risk pool, a phenomenon known as adverse selection. \nBy preventing these premium spikes and incentivizing lower-cost plans through proposed Health Savings Accounts, the Healthcare Price Cuts Act secures Oscar’s membership stability. This legislative clarity converts a major structural risk into a growth catalyst, fueling the stock's 25% weekly gain.\nWhat Else: Oscar Health, earlier this month, reported third-quarter revenue of $2.99 billion, falling short of the $3.08 billion consensus, while its operating loss deepened to $129.3 million despite a membership jump to 2.12 million.The company attributed the wider loss to an 88.5% medical loss ratio driven by higher market morbidity, yet it reaffirmed its full-year 2025 revenue outlook of $12 billion to $12.2 billion.\nBenzinga Edge Rankings: Benzinga Edge data currently highlights a Momentum score of 54.80, reflecting the stock’s technical positioning as it attempts to capitalize on the new regulatory tailwinds.\nOSCR Price Action: Oscar Health shares were up 9.23% at $18.28 at the time of publication on Wednesday, according to Benzinga Pro data.\nRead Also: What’s Going On With Johnson & Johnson Stock On Wednesday?\nBesides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. \nFor example, in Oscar Health’s case, it is in the Financials sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.\nImage: Shutterstock\nThis content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2586026199","isCrawlerRequest":true}